We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.37B
AUM Growth
-$13.6M
Cap. Flow
+$14.5M
Cap. Flow %
0.61%
Top 10 Hldgs %
39.42%
Holding
115
New
26
Increased
36
Reduced
14
Closed
20

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$60.1M
2
AMZN icon
Amazon
AMZN
+$54.1M
3
YUM icon
Yum! Brands
YUM
+$51M
4
RPRX icon
Royalty Pharma
RPRX
+$39.8M
5
ETNB
89bio
ETNB
+$28.8M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$102M
2
TPR icon
Tapestry
TPR
+$83M
3
LVS icon
Las Vegas Sands
LVS
+$78.1M
4
UNP icon
Union Pacific
UNP
+$56.7M
5
T icon
AT&T
T
+$54.3M

Sector Composition

Rank Sector Weight
1 Healthcare 47.29%
2 Consumer Discretionary 12.85%
3 Technology 6.69%
4 Communication Services 5.61%
5 Consumer Staples 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PROK icon
26
ProKidney
PROK
$337M
$36.1M 1.53%
3,193,175
– –
ORCL icon
27
Oracle
ORCL
$423B
$34.1M 1.44%
366,513
+8,200
+2% +$719K
ETNB
28
DELISTED
89bio
ETNB
$33.7M 1.42%
+2,210,536
New +$28.8M
MRNS
29
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$33.3M 1.41%
4,831,261
+8,266
+0.2% +$51.8K
KRE icon
30
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$29.1M 1.23%
+662,500
New +$37.6M
STRO icon
31
Sutro Biopharma
STRO
$421M
$26.3M 1.11%
568,909
+12,399
+2% +$787K
FIS icon
32
Fidelity National Information Services
FIS
$22.1B
$25.5M 1.08%
469,110
-223,895
-32% -$14.6M
XYZ
33
Block Inc
XYZ
$47.5B
$25.2M 1.07%
367,440
-476,863
-56% -$35.7M
PINS icon
34
Pinterest
PINS
$13.4B
$24.7M 1.05%
+907,560
New +$23.5M
RARE icon
35
Ultragenyx Pharmaceutical
RARE
$2.55B
$24.7M 1.04%
616,480
-200,691
-25% -$8.61M
SBUX icon
36
Starbucks
SBUX
$120B
$24.2M 1.02%
232,761
-215,280
-48% -$22.4M
KZR
37
DELISTED
Kezar Life Sciences
KZR
$21.6M 0.91%
688,759
+338,333
+97% +$19.6M
WBD icon
38
Warner Bros
WBD
$67.1B
$21.5M 0.91%
+1,425,726
New +$20.3M
PYPL icon
39
PayPal
PYPL
$50.5B
$20.1M 0.85%
+264,218
New +$20.4M
COF icon
40
Capital One
COF
$134B
$20M 0.84%
+207,600
New +$21.7M
COGT icon
41
Cogent Biosciences
COGT
$7.24B
$19.6M 0.83%
1,819,693
+8,297
+0.5% +$106K
GS icon
42
Goldman Sachs
GS
$303B
$18.9M 0.8%
+57,635
New +$20.1M
COR icon
43
Cencora
COR
$61.2B
$17.8M 0.75%
111,458
-13,200
-11% -$2.09M
KALV
44
DELISTED
KalVista Pharmaceuticals
KALV
$15.6M 0.66%
1,983,179
+910,877
+85% +$6.8M
FULC icon
45
Fulcrum Therapeutics
FULC
$297M
$14.8M 0.62%
5,177,710
+902,907
+21% +$8.09M
ALVO icon
46
Alvotech
ALVO
$1.29B
$12.9M 0.54%
1,000,000
– –
WFC icon
47
Wells Fargo
WFC
$264B
$12.6M 0.53%
+335,875
New +$14.6M
MRVL icon
48
Marvell Technology
MRVL
$196B
$12.5M 0.53%
+289,300
New +$12.2M
MTCH icon
49
Match Group
MTCH
$8.55B
$11.4M 0.48%
+296,801
New +$12.9M
ORIC icon
50
Oric Pharmaceuticals
ORIC
$1.4B
$10.8M 0.46%
1,902,643
– –
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Suvretta Capital Management held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management's Q1 2023 filing shows 26 new, 36 increased, 14 reduced and 20 closed positions. Its largest new stake was Amazon: 559,490 shares worth $57.8M. The largest sale was Otis Worldwide, an estimated $102M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Suvretta Capital Management's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
  • Suvretta Capital Management added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
  • Suvretta Capital Management's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
  • Suvretta Capital Management fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
  • Suvretta Capital Management opened 26 new positions and closed 20 in Q1 2023.
  • Suvretta Capital Management's portfolio value fell 0.57% quarter-over-quarter to $2.37B.

Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.